期刊文献+

Novel 2-aryl-3,4,5-trihydroxypiperidines:Synthesis and glycosidase inhibition

Novel 2-aryl-3,4,5-trihydroxypiperidines:Synthesis and glycosidase inhibition
原文传递
导出
摘要 Three pairs of novel 2-aryl-3,4,5-trihydroxypiperidines (6-8 and their enantiomers), the piperidine analogues of the pyrrolidine alkaloids radicamine A and radicamine B, were prepared from six- membered cyclic nitrones through a concise two-step procedure, i.e., Grignard reagent addition and deprotection. These novel polyhydroxylated piperidine iminosugars were assayed against 10 types of enzymes. Only compound 8 exhibited weak inhibition (IC50 1080 μmol/L) against β-galactosidase from rat intestinal lactases. Three pairs of novel 2-aryl-3,4,5-trihydroxypiperidines (6-8 and their enantiomers), the piperidine analogues of the pyrrolidine alkaloids radicamine A and radicamine B, were prepared from six- membered cyclic nitrones through a concise two-step procedure, i.e., Grignard reagent addition and deprotection. These novel polyhydroxylated piperidine iminosugars were assayed against 10 types of enzymes. Only compound 8 exhibited weak inhibition (IC50 1080 μmol/L) against β-galactosidase from rat intestinal lactases.
出处 《Chinese Chemical Letters》 SCIE CAS CSCD 2013年第12期1059-1063,共5页 中国化学快报(英文版)
基金 Financial support from National Basic Research Program of China (Nos. 2012CB822101 and 2011CB808603) the Natural Science Foundation of China (Nos. 21272240 and 21102149)
关键词 2-Aryl polyhydroxylated piperidine lminosugars Radicamine mimics Glycosidase inhibitors 2-Aryl polyhydroxylated piperidine lminosugars Radicamine mimics Glycosidase inhibitors
  • 相关文献

参考文献67

  • 1For books see:(a) A.E. Stiitz, Iminosugars as Glycosidase Inhibitors: Nojirimycin and Beyond, Wiley-VCH, Weinheim/New York, 1999.
  • 2P. Compain, O.R. Martin, Iminosugars: From Synthesis to Therapeutic Applications, John Wiley & Sons, England, 2007.
  • 3N. Asano, R.J. Nash, R.J. Molyneux, G.W.J. Fleet, Sugar-mimic glycosidase inhibitors: natural occurrence, biological activity and prospects for therapeutic application, Tetrahedron: Asymmetry 11 (2000) 1645-1680.
  • 4A.A. Watson, G.W.J. Fleet, N. Asano, R.J. Molyneux, R.J. Nash, Polyhydroxylated alkaloids - natural occurrence and therapeutic applications, Phytochemistry 56(2001) 265-295.
  • 5(a) G. Horne, F.X. Wilson, J. Tinsley, D.H. Williams, R. Storer, Iminosugars past, present and future: medicines for tomorrow, Drug Discovery Today 16 (2011) 107-118.
  • 6N. Asano, Glycosidase inhibitors: update and perspectives on practical use, Glycobiology 13 (2003) 93R-104R.
  • 7X.S. Ye, F. Sun, M. Liu, et al., Synthetic iminosugar derivatives as new potential immunosuppressive agents, J. Med. Chem. 48 (2005) 3688-3691.
  • 8(a) M. Shibano, D. Tsukamoto, G. Kusano, Polyhydroxylated alkaloids with lipophilic moieties as glycosidase inhibitors from higher plants, Heterocycles 57(2002)1539-1553.
  • 9M. Shibano, D. Tsukamoto, A. Masuda, Y. Tanaka, G. Kusano, Two new pyrrolidine alkaloids, radicanmines A and B, as inhibitors of a-glucosidase from lobelia chinensis LOUR, Chem. Pharm. Bull. 49 (2001) 1362-1365.
  • 10S. Ishida, M. Okasaka, F. Ramos, et al., Reply to: no effect of endogenous TRIM5a on HIV-1 production, Nat. Med. 62 (2008) 236-238.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部